| Human pluripotent stem cell-derived functional sympathetic neurons express ACE2 and RAAS components: a framework for studying the effect of COVID-19 on sympathetic responsiveness HF Wu, CW Huang, KR Daga, RA Marklein, N Ivanova, N Zeltner Clinical Autonomic Research 32 (1), 59-63, 2022 | 3 | 2022 |
| DEVELOPMENT OF A HIGH-THROUGHPUT MICROGLIA MORPHOLOGICAL PROFILING ASSAY TO ASSESS MESENCHYMAL STROMAL CELL EXTRACELLULAR VESICLE POTENCY KR Daga, K Chen, AM Larey, CE Campagna, TS Maughon, R Marklein CYTOTHERAPY 24 (5), S60-S61, 2022 | 2 | 2022 |
| Shape up before you ship out: morphology as a potential critical quality attribute for cellular therapies KR Daga, P Priyadarshani, AM Larey, K Rui, LJ Mortensen, RA Marklein Current opinion in biomedical engineering 20, 100352, 2021 | 2 | 2021 |
| HIGH THROUGHPUT SCREENING OF MESENCHYMAL STROMAL CELL MORPHOLOGICAL RESPONSE TO INFLAMMATORY SIGNALS FOR BIOREACTOR-BASED MANUFACTURING OF IMMUNOMODULATORY EXTRACELLULAR VESICLES AM Larey, KR Daga, CE Campagna, TS Maughon, T Spoerer, K Chen, ... CYTOTHERAPY 24 (5), S56-S57, 2022 | 1 | 2022 |
| Mesenchymal Stem/Stromal Cells: DEVELOPMENT OF A HIGH-THROUGHPUT MICROGLIA MORPHOLOGICAL PROFILING ASSAY TO ASSESS MESENCHYMAL STROMAL CELL EXTRACELLULAR VESICLE POTENCY KR Daga, K Chen, AM Larey, CE Campagna, TS Maughon, R Marklein Cytotherapy 24 (5), S60-S61, 2022 | | 2022 |
| Mesenchymal Stem/Stromal Cells: HIGH THROUGHPUT SCREENING OF MESENCHYMAL STROMAL CELL MORPHOLOGICAL RESPONSE TO INFLAMMATORY SIGNALS FOR BIOREACTOR-BASED MANUFACTURING OF … AM Larey, KR Daga, CE Campagna, TS Maughon, T Spoerer, K Chen, ... Cytotherapy 24 (5), S56-S57, 2022 | | 2022 |
| Mesenchymal Stem/Stromal Cells: DEVELOPMENT OF A MORPHOLOGICAL PERICYTE POTENCY ASSAY FOR MSC-EVS USE IN THE CONTEXT OF NEUROINFLAMMATION CE Campagna, M Roos, TS Maughon, AM Larey, KR Daga, S Ghosh, ... Cytotherapy 24 (5), S47-S48, 2022 | | 2022 |
| Development of a morphology-based microglia potency assay to assess the therapeutic potential of MSCs for neurodegenerative diseases KR Daga, K Chen, R Marklein Cytotherapy (Oxford, England) 23 (5), S40-S41, 2021 | | 2021 |
